TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←

Serva

private
sign in to save

Serva is a privately held company tracked for investment-relevant business and technology developments.

sentiment mix
bull 100%bear 0%neu 0%

funding rounds

private markets
awaiting round data

This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.

signal summary

latest high-conviction thesis
Serva designs personalized oncology drugs from blood droplet in hours, already dosing patients▾

Serva uses AI models trained on proprietary data to design personalized oncology drugs under single-patient INDs, moving from blood droplet to treatment in hours, already dosing patients including the GitLab founder's cancer vaccine, with £8M pre-seed raised.

mattT1Scaling Europe2026-06-03
confidence 88 / 100impact High
key themes
  • AI Economics & Business Models100%
  • AI Agents100%
  • AI Talent & Labor Market100%
  • Venture Capital100%

bull thesis · 1

95 / 100
  • •Serva designs personalized oncology drugs from blood droplet in hours, already dosing patients

bear thesis · 0

—
  • — none —

mentions · 1

Scaling EuropeOnStage Demo Day 20261 mentions · 1▲ 0▼ 0○ · 4 months ago
0:0011:0022:0033:0045:00